Objectives To analyze the short-term effects of holmium laser enucleation of the prostate(HoLEP) and transurethral resection of the prostate(TURP) in the treatment of benign prostatic hyperplasia. Methods 120 patients with prostatic hyperplasia in our hospital were randomly divided into 2 groups from January 2011 to December 2014. The patients in group A underwent HoLEP, while the group B underwent TURP. Quality of life score (QOL), maximum urinary flow rate (Qmax), the international prostate symptom score (IPSS) and efficacy of two groups were recorded and compared between perioperative period and 1, 6, 12 months after operation. Results There were no statistically significance in quality of life scores, maximum urinary flow rate, the international prostate symptom score, the prostate weight and residual urine volume between the two groups before operation (t=0.665, 0.441, 0.639, 0.758, 0.778, P=0.508, 0.660, 0.524, 0.660, 0.524). The bleeding in the surgery, the average incidence of hyponatremia, the bladder indwelling catheter and washing time was(78.25 ±25.78) mL, 5%, (2.37 ± 1.35) d, (1.25±0.49) d in group A, respectively. And the group B was(136.78 ±29.45) mL, 25%, (5.34±2.02) d, (2.54±0.78) d, respectively. Group B was significantly higher than group A(P<0.05). At the same time, quality of life scores, maximum urinary flow rate, the international prostate symptom score 1, 6, 12 months after operation were improved than before treatment, and the indicators in group A were improved than group B(P<0.05). Conclusions The efficacy and safety of HoLEP in the treatment of patients with benign prostatic hyperplasia are better than that of TURP. It is a good treatment for benign prostatic hyperplasia. Key words: Prostatic Hyperplasia; Laser Therapy; Electrosurgery